340 related articles for article (PubMed ID: 8973428)
1. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
[TBL] [Abstract][Full Text] [Related]
4. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
Villanueva C; Balanzó J; Novella MT; Soriano G; Sáinz S; Torras X; Cussó X; Guarner C; Vilardell F
N Engl J Med; 1996 Jun; 334(25):1624-9. PubMed ID: 8628357
[TBL] [Abstract][Full Text] [Related]
5. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
García-Pagán JC; Villanueva C; Albillos A; Bañares R; Morillas R; Abraldes JG; Bosch J;
Gut; 2009 Aug; 58(8):1144-50. PubMed ID: 19218249
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale.
Merkel C; Gatta A; Donada C; Enzo E; Marin R; Amodio P; Torboli P; Angeli P; Cavallarin G; Sebastianelli G
Hepatology; 1995 Sep; 22(3):808-13. PubMed ID: 7657286
[TBL] [Abstract][Full Text] [Related]
7. Should nitrates be used with beta blockers to prevent variceal bleeding?
Zalepuga R; Herrera JL
Am J Gastroenterol; 2000 Oct; 95(10):2982-3. PubMed ID: 11051383
[No Abstract] [Full Text] [Related]
8. Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients.
Wang HM; Lo GH; Chen WC; Tsai WL; Chan HH; Cheng LC; Hsu PI; Lai KH
J Chin Med Assoc; 2006 Oct; 69(10):453-60. PubMed ID: 17098669
[TBL] [Abstract][Full Text] [Related]
9. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
Lo GH; Chen WC; Wang HM; Yu HC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
[TBL] [Abstract][Full Text] [Related]
10. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
Lo GH; Chen WC; Chen MH; Hsu PI; Lin CK; Tsai WL; Lai KH
Gastroenterology; 2002 Sep; 123(3):728-34. PubMed ID: 12198699
[TBL] [Abstract][Full Text] [Related]
11. Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
Borroni G; Salerno F; Cazzaniga M; Bissoli F; Lorenzano E; Maggi A; Visentin S; Panzeri A; de Franchis R
J Hepatol; 2002 Sep; 37(3):315-21. PubMed ID: 12175626
[TBL] [Abstract][Full Text] [Related]
12. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
Sarin SK; Wadhawan M; Gupta R; Shahi H
Dig Dis Sci; 2005 Aug; 50(8):1538-47. PubMed ID: 16110851
[TBL] [Abstract][Full Text] [Related]
14. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
García-Pagán JC; Morillas R; Bañares R; Albillos A; Villanueva C; Vila C; Genescà J; Jimenez M; Rodriguez M; Calleja JL; Balanzó J; García-Durán F; Planas R; Bosch J;
Hepatology; 2003 Jun; 37(6):1260-6. PubMed ID: 12774003
[TBL] [Abstract][Full Text] [Related]
15. Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.
Kong DR; Ma C; Wang M; Wang JG; Chen C; Zhang L; Hao JH; Li P; Xu JM
World J Gastroenterol; 2013 Jul; 19(26):4228-33. PubMed ID: 23864788
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy for secondary prophylaxis of variceal rebleeding?
Maldonado D; Barkin JS
Am J Gastroenterol; 2002 Aug; 97(8):2134-6. PubMed ID: 12190191
[No Abstract] [Full Text] [Related]
17. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Bolognesi M; Sacerdoti D; Merkel C; Gatta A
J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
[TBL] [Abstract][Full Text] [Related]
18. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
Sharma P; Kumar A; Sharma BC; Sarin SK
Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
[TBL] [Abstract][Full Text] [Related]
19. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Bosch J
P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Villanueva C; Aracil C; Colomo A; Lopez-Balaguer JM; Piqueras M; Gonzalez B; Torras X; Guarner C; Balanzo J
Aliment Pharmacol Ther; 2009 Feb; 29(4):397-408. PubMed ID: 19006538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
